Amyris, IDRI to Engineer Molecules for Vaccine Adjuvant Applications - Pharmaceutical Technology Magazine
Amyris, IDRI to Engineer Molecules for Vaccine Adjuvant Applications Pharmaceutical Technology MagazineOn Feb. 12, 2019, Amyris, an integrated renewable products company, announced that it has been selected by the Infectious Disease Research Institute (IDRI), ...